DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 5 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,197 | +14.3% | 555 | 0.0% | 0.00% | – |
| Q2 2023 | $7,171 | +114.4% | 555 | +62.8% | 0.00% | – |
| Q1 2023 | $3,345 | +362.0% | 341 | +401.5% | 0.00% | – |
| Q4 2022 | $724 | -63.8% | 68 | -53.1% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 145 | +113.2% | 0.00% | – |
| Q2 2022 | $1,000 | -99.8% | 68 | -99.9% | 0.00% | -100.0% |
| Q4 2021 | $645,000 | +32150.0% | 45,870 | +18248.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 250 | -28.6% | 0.00% | – |
| Q1 2021 | $3,000 | -40.0% | 350 | -50.0% | 0.00% | – |
| Q1 2019 | $5,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |